Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study on RNAi technology targeting neurodegenerative diseases

Study on RNAi technology targeting neurodegenerative diseases

Benefits from short-term hormone therapy are likely to outweigh the risks

Benefits from short-term hormone therapy are likely to outweigh the risks

British team and NASA plan to take stem cells into space

British team and NASA plan to take stem cells into space

Alzheimer’s sufferers are more likely to have jobs that are less mentally challenging than people without Alzheimer’s disease

Alzheimer’s sufferers are more likely to have jobs that are less mentally challenging than people without Alzheimer’s disease

Approval of Cymbalta for treatment of major depressive disorder

Approval of Cymbalta for treatment of major depressive disorder

Nogo protein may control the progression of Alzheimer’s disease

Nogo protein may control the progression of Alzheimer’s disease

Study evaluated the ability of vitamin E and Aricept, to delay the progression of mild cognitive impairment to Alzheimer's disease

Study evaluated the ability of vitamin E and Aricept, to delay the progression of mild cognitive impairment to Alzheimer's disease

Scientists have produced a prion protein that can trigger the development of a neurological disorder similar to "mad cow" disease

Scientists have produced a prion protein that can trigger the development of a neurological disorder similar to "mad cow" disease

Adenosine triphosphate is a culprit in causing the devastating damage of spinal cord injury

Adenosine triphosphate is a culprit in causing the devastating damage of spinal cord injury

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

Research collaboration to discover novel oral drugs for the treatment of viral infections

Research collaboration to discover novel oral drugs for the treatment of viral infections

75 percent of Americans support call for more stem cell research

75 percent of Americans support call for more stem cell research

New plan of action aims to reduce prescription drug costs by more than 50 percent

New plan of action aims to reduce prescription drug costs by more than 50 percent

Donepezil may have short-term benefit for mild cognitive impairment

Donepezil may have short-term benefit for mild cognitive impairment

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

First well-conducted studies of use of antipsychotics in people with Alzheimer’s

First well-conducted studies of use of antipsychotics in people with Alzheimer’s

Effects of Huntington's disease mutation more complex than originally thought

Effects of Huntington's disease mutation more complex than originally thought

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Difficulties in performing day to day tasks could indicate the presence of mild cognitive impairment

Difficulties in performing day to day tasks could indicate the presence of mild cognitive impairment

Donepezil may have short-term benefit for mild cognitive impairment

Donepezil may have short-term benefit for mild cognitive impairment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.